Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultroid Technologies is a medical device company specializing in the development and commercialization of non-surgical treatments for hemorrhoids. The company's flagship product, the Ultroid System, is an FDA-cleared medical device that utilizes a low-voltage micro-current to treat all grades of internal hemorrhoids. This minimally invasive procedure triggers a natural chemical reaction that shrinks the hemorrhoidal tissue without the need for anesthesia, incisions, or significant recovery time. The technology is designed for use in a physician's office, providing a rapid and painless alternative to traditional surgical interventions like hemorrhoidectomy or rubber band ligation. Patients typically return to normal activities immediately following the 10-to-15-minute procedure. Ultroid Technologies focuses on providing a safe, effective, and cost-efficient solution for both patients and healthcare providers in the field of proctology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultroid Technologies.